TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director September 24, 1976
TCL Archive Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer July 29, 2011
